Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer.

Cancer letters - 28 Oct 2015

Heidegger Isabel, Massoner Petra, Sampson Natalie, Klocker Helmut

Abstract excerpt

Prostate cancer (PCa) is the most common cancer and the second leading cause of cancer death in males. In recent years, several new targeting agents have been introduced for the treatment of advanced stages of the disease. However, development of resistance limits the efficacy of new drugs and there is a further need to develop additional novel treatment approaches. One of the most investigated targets in cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prostatic Neoplasms
Share to Antibodies, Monoclonal
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Design

Share to Insulin-Like Growth Factor I

Share to Molecular Targeted Therapy

Share to Protein Kinase Inhibitors

Share to Receptor, IGF Type 1

Source

Identifiers

PMID: 26231734
DOI: 10.1016/j.canlet.2015.07.026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer.PMID 26231734Read ↗

Diverse Functions of IGF/Insulin Signaling in Malignant and Noncancerous Prostate Cells: Proliferation in Cancer Cells and Differentiation in Noncancerous CellsSemantic proximity Read ↗

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysisSemantic proximity Read ↗

AR Signaling and the PI3K Pathway in Prostate CancerSemantic proximity Read ↗

Targeting the IGF1 axis in cancer proliferationSemantic proximity Read ↗

The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical ApplicationsSemantic proximity Read ↗

Molecular mechanisms in hormone-resistant prostate cancer.Semantic proximity Read ↗

Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapySemantic proximity Read ↗

Insulin‐like growth factor ligands, receptors, and binding proteins in cancerSemantic proximity Read ↗

[The mechanisms of prostate cancer progression through androgen receptor].Semantic proximity Read ↗

Tumor Suppressor BRCA1 Is Expressed in Prostate Cancer and Controls Insulin-like Growth Factor I Receptor (IGF-IR) Gene Transcription in an Androgen Receptor–Dependent MannerSemantic proximity Read ↗

Interplay between the androgen receptor signaling axis and microRNAs in prostate cancerSemantic proximity Read ↗

The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent InsightsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.